Posts by: admin

News, Pneumonia

Cempra announced positive results from its Phase 3 multicenter trial of oral solithromycin versus oral moxifloxacin for community-acquired bacterial pneumonia. The clinical study, which appeared in the medical journal Lancet, found solithromycin to be of similar ... Read more

February 15, 2016February 18, 2016

In Certain People with PAH, Researchers Identify Markers for Lower Mortality Rates

News, Pulmonary Hypertension, Scleroderma

A new study demonstrated that specific antibodies could be markers for decreased mortality in people with connective tissue disease and systemic sclerosis associated with pulmonary arterial hypertension (PAH). The report in ... Read more

February 4, 2016February 4, 2016

Study of 2 Lung Diseases Shows No Genetic Link

News, Pneumonia, Scleroderma

A new study reports that although lung disease in systemic sclerosis (SSc) shares similarities with idiopathic interstitial pneumonia, the disorders do not have a common genetic basis. The article, titled ... Read more

January 20, 2016January 21, 2016

Rhinovirus-positive Bronchiolitis Increases Use of Asthma Medication in Kids, Study Shows

Asthma, Bronchiolitis, News

A new study from Finland showed that children with rhinovirus-positive bronchiolitis used asthma controller medication more often than kids with respiratory syncytial virus. Understanding risk factors for asthma may aid in its prevention, or ... Read more

January 19, 2016January 19, 2016

Key to Unlocking Cause of Bronchopulmonary Dysplasia Revealed in New Study

News

Scientists at UT Southwestern Medical Center may have found a key to understand what causes bronchopulmonary dysplasia (BPD), a lung disease found in premature infants that can be fatal. According to the new study, the ... Read more

January 18, 2016January 19, 2016

Drug’s Safety for Idiopathic Pulmonary Fibrosis Supported by 5 Clinical Trials

Idiopathic Pulmonary Fibrosis, News

Research from an international, collaborative group of scientists, led by researchers at Vanderbilt University in Tennessee, supports the safety of pirfenidone as a therapy for idiopathic pulmonary fibrosis (IPF). The ... Read more

January 14, 2016January 14, 2016

Having Cystic Fibrosis Appears to Increase Chance of Lung Transplant Rejection

Cystic Fibrosis, News

Lung transplants are rejected in about 40 percent of those who receive them, but the incidence of rejection is even higher among people with cystic fibrosis (CF), according to a ... Read more

September 22, 2015November 6, 2015

Boehringer Ingelheim to Present New Data for COPD, IPF and Asthma at European Respiratory Society International Congress

Asthma, Idiopathic Pulmonary Fibrosis, News

Boehringer Ingelheim plans to roll out several major presentations focusing for its respiratory disease portfolio at the upcoming European Respiratory Society (ERS) International Congress, September 26-30. The German company is currently ... Read more

September 14, 2015November 9, 2015

GSK and Theravance’s SUMMIT COPD CV Survival Study Fails to Achieve Primary Endpoint

COPD, News

GlaxoSmithKline and Theravance, Inc. have announced results from the Study to Understand Mortality and MorbidITy (SUMMIT) in chronic obstructive pulmonary disease (COPD). This was a Phase 3 clinical trial of ... Read more

August 11, 2015October 28, 2015

New Experimental Lung Cancer Therapy Overstimulates and Kills Cancer Cells

Lung Cancer, News

In the photo shown, cancer cells were treated with a control (left) and the overstimulating compound MCB-613 (right). CREDIT Lei Wang A new, potentially promising drug overstimulates proteins that are needed ... Read more